Profitability Metrics

Gross Margin
18.52%
Operating Margin
15.97%
Net Margin
15.64%

Efficiency Metrics

Revenue per Expense Ratio
1.19
R&D as % of Revenue
0.00%

Earnings Quality

EBITDA Margin
24.11%
Income Tax Rate
15.83%
EPS
2.0100000000

Balance Sheet Analysis

Current Ratio
0.91
Cash Ratio
0.18
Working Capital
$-1.22B
Debt to Equity
0.45
Debt to Assets
18.66%
Equity Ratio
41.44%

Cash Flow Analysis

Operating Cash Flow Ratio
18.03%
Free Cash Flow Ratio
14.60%
CapEx to Revenue
3.43%
Dividends Paid
$1.82B
Stock Buybacks
No buybacks
Total Shareholder Returns
$1.82B
Cash Position Change
292.80%

Key Takeaways (2023 FY)

  • Maintained positive net income growth despite revenue changes

Detailed Growth Metrics

Core Performance

Revenue
6.93%
Net Income
40.86%
EPS
8.06%
Operating Income
3.49%

Operational Efficiency

R&D Expenses
-100.00%
SG&A Expenses
-36.57%
Operating Cash Flow
0.47%
Free Cash Flow
-14.86%

Balance Sheet Health

Assets
2.48%
Debt
-6.14%
Book Value per Share
-12.94%
Inventory
0.00%

Shareholder Returns

Dividends per Share
-33.03%
Shares Outstanding
30.00%

Long Term Trends

3Y Revenue/Share
12.36%
5Y Revenue/Share
41.94%
3Y Dividend/Share
134.45%
5Y Dividend/Share
207.18%